Optimalisering av kreftbehandling med tamoxifen
- Prosjektnummer
- 911168
- Ansvarlig person
- Jennifer Gjerde
- Institusjon
- Helse Bergen HF
- Prosjektkategori
- Forskerutdanning - dr.grad
- Helsekategori
- Endocrinology & Metabolism
- Forskningsaktivitet
- Translasjonsforskning
Tamoxifen impairs both longitudinal and cortical bone growth in young male rats.
J Bone Miner Res 2008 Aug;23(8):1267-77.
PMID: 18348701
Effects of CYP2D6 and SULT1A1 genotypes including SULT1A1 gene copy number on tamoxifen metabolism.
Ann Oncol 2008 Jan;19(1):56-61. Epub 2007 okt 18
PMID: 17947222
Randomized dose-ranging trial of tamoxifen at low doses in hormone replacement therapy users.
J Clin Oncol 2007 Sep;25(27):4201-9. Epub 2007 aug 20
PMID: 17709798
Induction of hepatic drug-metabolising enzymes and tamoxifen metabolite profile in relation to administration route during low-dose treatment in nude rats.
J Steroid Biochem Mol Biol 2005 Apr;94(5):489-98. Epub 2005 apr 7
PMID: 15876414
Identification and quantification of tamoxifen and four metabolites in serum by liquid chromatography-tandem mass spectrometry.
J Chromatogr A 2005 Jul;1082(1):6-14.
PMID: 16038189
Effect of CYP2D6 and SULT1A1 Genotypes on the serum concentration of 4-OHtamoxifen and 4-OH-N-Demethyltamoxifen
The Breast
A study of associations between estrogen and tamoxifen metabolism, cytochrome 2D6 and sulfotransferase 1A1 polymorphisms
Breast Cancer Research Treatment
Relationship between CYP2D6 and SULT1A1 genotypes and serum concentrations of tamoxifen and its metabolites during steady state
San Antonio Breast Cancer Symposium, 2005
Tamoxifen treatment of breast cancer: Pharmacogenetics and therapeutic drug monitoring
- Disputert:
- juni 2008
- Hovedveileder:
- Ernst A. Lien
eRapport er utarbeidet av Sølvi Lerfald og Reidar Thorstensen, Regionalt kompetansesenter for klinisk forskning, Helse Vest RHF, og videreutvikles av de fire RHF-ene i fellesskap, med støtte fra Helse Vest IKT
Alle henvendelser rettes til Faglig rapportering, Helse Vest